Seeking Alpha

Sarepta Therapeutics, Inc. (SRPT)

There are 2 articles on this stock available only to PRO subscribers.
From other sites
SRPT vs. ETF Alternatives
Company Description
Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.
Sector: Healthcare
Industry: Biotechnology
Country: United States